Trial Profile

A Phase III Trial to Evaluate Once-Monthly (Once Every Four Weeks) Intramuscular Route of Administration of Ibalizumab

Status: Recruiting

Phase of Trial: Phase III

Latest Information Update: 19 Jul 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

19 May 2021 According to a TaiMed Biologics media release, company made the agreement with Theratechnologies Inc. to initiate this study. Related costs and expenses will be paid by Theratechnologies Inc. and no effect on the profit sharing of the marketing agreement.
19 May 2021 Status changed from planning to recruiting, according to a TaiMed Biologics media release.
14 Apr 2021 According to a Theratechnologies media release, Theratechnologies and TaiMed are planning to evaluate an intramuscular (IM) method of administration for Trogarzo and the study will be conducted and funded by Theratechnologies.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com